Skip to main content

Chronic Urticaria — Deal Benchmarks & Valuation

Median Upfront
$375M
Range: $206M - $538M
Total Deal Value
$2.0B
Range: $1.3B - $2.7B
Royalty Rate
6.4% - 12.9%
Tiered up to 16.9%
Dev Milestones
$329M
Range: $222M - $438M
Model Your Deal

Market Analysis

Chronic Urticaria is one of the most actively transacted indications in dermatology licensing. Phase 2 deals for chronic urticaria carry a median total deal value of $2.0B, with upfront payments ranging from $206M to $538M. The recommended deal structure allocates approximately 19% to upfront payments and 81% to milestones.

Milestone structures for chronic urticaria deals allocate $329M to development milestones, $412M to regulatory milestones, and $905M to commercial milestones. Royalty rates range from 6.4% to 12.9% at the base tier, with tiered escalation reaching 10.4%-16.9% on peak sales.

Customize these benchmarks for your asset

Adjust phase, modality, competitive position, and 10+ other parameters.

Open Calculator

Frequently Asked Questions

What are typical deal terms for chronic urticaria licensing?
Phase 2 chronic urticaria licensing deals average $375M in upfront payments with $2.0B total deal value. The 19/81 upfront/milestone split reflects the risk profile at this clinical stage.
What royalty rates are standard for chronic urticaria deals?
Base royalty rates for chronic urticaria transactions range from 6.4% to 12.9%, with tiered escalations reaching 10.4%-16.9% on peak sales. Rates are influenced by mechanism differentiation, competitive positioning, and territorial scope.
How are chronic urticaria deal milestones structured?
Chronic Urticaria deals allocate approximately 81% of total deal value to milestones. Development milestones ($329M) make up the largest share, followed by commercial milestones ($905M) and regulatory milestones ($412M).
PRO

Full Benchmark Analysis

Complete deal term ranges, comparable transactions, and negotiation insights.

Start 7-Day Free Trial

$299/mo after trial · Cancel anytime

Related Benchmarks

Atopic Dermatitis Deals

View

Alopecia Areata Deals

View

Hidradenitis Suppurativa Deals

View

Dermatology Deal Overview

View

Ready to Calculate Your Deal Terms?

Get instant, customized benchmarks based on real market data from 1,600+ biopharma licensing deals.

Start Calculating
For Funds & Advisors

Need the full deal landscape?

The Deal Intelligence Brief covers every modality and deal structure for this indication — 52 deal calculations, AI strategic narrative, comparable transactions, partner matching, and white-label branding. Delivered in 24 hours.

Configure Brief — $2,500All-inclusive · White-label · Walkthrough included